Your Health, We Care
brigatinib is a reversible dual inhibitor of ALK and epidermal growth factor receptor (EGFR), with activity against various kinases including ALK, ROS1, insulin-like growth factor 1 receptor (IGF-1R), etc.
It exerts its effect by inhibiting ALK phosphorylation and activation of downstream signaling proteins, and has a significant inhibitory effect on ALK positive tumor cells.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
